| Literature DB >> 26621197 |
Olivier Leroy1, Hugues Georges2, Patrick Devos3, Steve Bitton4, Nathalie De Sa5, Céline Dedrie6, Sébastien Beague7, Pierre Ducq8, Claire Boulle-Geronimi9, Damien Thellier10, Fabienne Saulnier11, Sebastien Preau12.
Abstract
BACKGROUND: Very few studies focused on patients with severe infective endocarditis (IE) and multiple complications leading to Intensive Care Unit (ICU) admission. Studied primary outcomes depended on the series and multiple prognostic factors have been identified. Our goal was to determinate characteristics of patients, in-hospital mortality and independent prognostic factors in an overall population of patients admitted to ICU for a left-sided, definite, active and severe IE.Entities:
Keywords: Cardiac surgery; Critical care medicine; Infectious diseases; Infective endocarditis; Prognostic
Year: 2015 PMID: 26621197 PMCID: PMC4666184 DOI: 10.1186/s13613-015-0091-7
Source DB: PubMed Journal: Ann Intensive Care ISSN: 2110-5820 Impact factor: 6.925
Main patients’ characteristics on ICU admission and on IE diagnosis
| Patients’ characteristics | |
|---|---|
| Age (years) | 62.4 ± 13.3 |
| Sex: M/F | 158/90 |
| Charlson score | 4.58 ± 2.70 |
| SAPS II | 36.7 ± 16.7 |
| SOFA score | 7.0 ± 3.7 |
| Main indications for ICU admission | |
| Septic shock | 54 (21.8) |
| Severe valvular regurgitation | 46 (18.55) |
| Cardiogenic shock | 39 (15.7) |
| Acute renal failure | 36 (14.5) |
| Acute respiratory failure requiring mechanical ventilation | 28 (11.3) |
| Neurological complications | 17 (6.85) |
| Community-acquired/hospital-acquired IE | 215 (86.7)/33 (13.3) |
| Native valve/prosthetic valve IE | 195 (78.6)/53 (21.4) |
| Valve involvement | |
| Aortic | 156 |
| Mitral | 152 |
| Tricuspid | 9 |
| Pulmonary | 1 |
| Multiple valve involvement | 66 |
| Aortic plus mitral valves | 53 |
| Aortic plus tricuspid valves | 3 |
| Aortic plus pulmonary valves | 1 |
| Aortic plus mitral plus tricuspid valves plus CIED | 1 |
| Aortic plus mitral valves plus CIED | 3 |
| Aortic valve plus CIED | 1 |
| Mitral plus tricuspid valves | 3 |
| Mitral plus tricuspid valves plus CIED | 1 |
| Portal of entry of IE | 126 (50.8) |
| Skin or soft tissue | 36 |
| Dental | 24 |
| Upper respiratory tract | 9 |
| Genitourinary tract | 13 |
| Digestive tract | 23 |
| Intra-venous drug abuse | 2 |
| Cardiovascular procedure or vascular access | 19 |
The results are given as n (%) or median ± SD
When indicated SAPS II Simplified Acute Physiologic Score II, SOFA sepsis-related organ failure assessment score, CIED cardiac implantable electronic device
Causative microorganisms (n = 235) isolated from cases of active IE
| Micro organism |
|
|---|---|
|
| 107 (45.6) |
| Beta-haemolytic | 27 |
| Oral | 24 |
| | 24 |
| Group D | 19 |
| | 13 |
|
| 90 (38.3) |
| Methicillin-susceptible | 74 |
| Methicillin-resistant | 16 |
| Coagulase-negative | 12 (5.1) |
| Gram-negative bacilli | 14 (6.0) |
| | 2 |
| | 11 |
| | 1 |
| Gram positive bacilli | 1 (0.4) |
|
| 4 (1.7) |
| Other | 7 (3.05) |
Main Indications and contra-indications for valvular surgery during ICU stay
| Timing of surgery | Indications | Number of patients with contra-indications | Contra-indications |
|---|---|---|---|
| Emergency | Cardiogenic shock | 33 (47.8 %) | Multiple organ failure |
| Urgent | Very large vegetations = 43 | 50 (49 %) | Risk of cerebral hemorrhage |
| Elective | Severe regurgitation without heart failure | 2 (13.3 %) | Severe underlying diseases |
In hospital mortality according to surgery during ICU stay and in-hospital mortality
| Timing of surgery | Number of patients | Number of patients with surgery performed during ICU stay | In hospital mortality | Number of patients with surgery not performed during ICU stay | In hospital mortality |
|---|---|---|---|---|---|
| Patients with contra-indications to surgery | |||||
| Emergency | 33 | 6 | 1 (16.7 %) | 27 | 25 (92.6 %) |
| Urgent | 50 | 8 | 1 (12.5 %) | 42 | 30 (71.4 %) |
| Elective | 2 | 1 | 0 | 1 | 0 |
| Patients without contra-indications to surgery | |||||
| Emergency | 36 | 36 | 6 (16.6 %) | 0 | 0 |
| Urgent | 52 | 41 | 11 (21.2 %) | 11 | 0 |
| Elective | 13 | 7 | 0 | 6 | 2 (33.3 %) |
Bivariate analysis of risk factors for in-hospital mortality
| Factor | Survivors | Non-survivors |
|
|---|---|---|---|
| Charlson score | 4.18 ± 2.80 | 5.15 ± 2.46 | 0.003 |
| SAPS II | 30.99 ± 13.16 | 44.60 ± 17.95 | <0.0001 |
| SAPS II > 35 | 43 (38.4 %) | 69 (61.6 %) | <0.0001 |
| SOFA score | 5.65 ± 2.77 | 8.93 ± 3.91 | <0.0001 |
| SOFA score >8 | 30 (33 %) | 61 (67 %) | <0.0001 |
| Glasgow Coma Score <9 | 7 (17.9 %) | 32 (82.1 %) | <0.0001 |
| ICU admission for septic shock | 17 (31.5 %) | 37 (68.5 %) | <0.0001 |
| ICU admission for cardiogenic shock | 16 (41 %) | 23 (59 %) | 0.016 |
| ICU admission for acute respiratory failure | 22 (78.6 %) | 6 (21.4 %) | 0.02 |
| ICU admission for severe valvular regurgitation | 40 (87 %) | 6 (13 %) | <0.0001 |
| Mitral IE | 80 (52.6 %) | 72 (47.4 %) | 0.02 |
| Native IE | 121 (62.05 %) | 74 (37.95 %) | 0.03 |
| Prosthetic IE | 24 (45.3 %) | 29 (54.7 %) | 0.03 |
| Annular abscess | 31 (46.3 %) | 36 (53.7 %) | 0.02 |
| Severe aortic regurgitation | 50 (75.8 %) | 16 (24.2 %) | 0.0009 |
| Left ventricular ejection fraction (%) | 57 ± 11 | 52 ± 13 | 0.005 |
| IE due to | 72 (67.3 %) | 35 (32.7 %) | 0.01 |
| IE due to MSSA | 36 (48.70 %) | 38 (51.3 %) | 0.04 |
| IE due to MRSA | 4 (25 %) | 12 (75 %) | 0.005 |
| Adequate antimicrobial treatment | 127 (61.7 %) | 79 (38.3 %) | 0.02 |
| Surgery during ICU stay | 80 (80.8 %) | 19 (19.2 %) | <0.0001 |
| Surgery (overall) | 102 (81.6 %) | 23 (18.4 %) | <0.0001 |
| Adequate surgery | 65 (85.5 %) | 11 (14.5 %) | <0.0001 |
MSSA methicillin-susceptible Staphylococcus aureus, MRSA methicillin-resistant Staphylococcus aureus